The fund-raising values the company at $3.8 billion and underscores investor interest in using artificial intelligence to tackle problems like drug discovery.
Business
·
Chai Discovery, an A.I. Drug Start-Up, Raises $400 Million
CN
CitrixNews Staff
Originally reported by New York Times. Read the full story at the original source.
Related Articles
Business
Why we’re stuck with a Premier League in the clutches of the global mega-rich | Jonathan Wilson
There’s little prospect of the model changing in a country that welcomes wealthy international owners with open armsFoot...
CitrixNews Staff
·
7 hours ago
Business
United Auto Workers president Shawn Fain easily wins re-election
Shawn Fein speaks at the the national conference of the UAW’s political arm in Washington DC on 9 February 2026. Photog...
CitrixNews Staff
·
12 hours ago
Business
What’s Dragging Down A.I. Efficiency? The ‘Verification Tax.’
As artificial intelligence automates office tasks, it is also creating a new type of human work.
CitrixNews Staff
·
14 hours ago
Business
From BJ’s to Lululemon, retailers are trimming assortments to boost business
Retailers are trimming assortments in an effort to clean up their balance sheets. As shoppers cut spending in the face o...
CitrixNews Staff
·
14 hours ago